Robert S. Huckman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Robert S. Huckman has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Budhaditya Gupta
Harvard Business School, USA
1 shared publication Darren E. Zinner
Harvard Business School, Boston, Massachusetts, U.S.A.
1 shared publicationDavid M. Cutler
Harvard University - Department of Economics; National Bureau of Economic Research (NBER); Harvard University - Harvard Kennedy School (HKS)
1 shared publicationGary P. Pisano
1 shared publicationJonathan Kolstad
Harvard University - Faculty of Arts and Sciences
1 shared publication- Tarun Khanna
Harvard Business School
1 shared publication
Latest Publications
- 1 December 2015
- Published by Elsevier in Healthcare
- Vol. 3 (4) , 245-250
Task shifting in surgery: Lessons from an Indian Heart Hospital
- 1 December 2015
- Published by Elsevier in Healthcare
- Vol. 3 (4) , 245-250
Task shifting in surgery: Lessons from an Indian Heart Hospital
- 1 July 2009
- Published by Elsevier in SSRN Electronic Journal
Input Constraints and the Efficiency of Entry: Lessons from Cardiac Surgery
Prior studies suggest that, with elastically supplied inputs, free entry may lead to an inefficiently high number of firms in equilibrium. Under input scarcity, however, the welfare loss from free entry is reduced. Further, free entry may increase use of high-quality inputs, as oligopolistic firms underuse these inputs when entry is constrained. We assess these predictions by examining how the 1996 repeal of certificate-of-need (CON) legislation in Pennsylvania affected the market for cardiac surgery in the state. We show that entry led to a redistribution of surgeries to higher-quality surgeons and that this entry was approximately welfare neutral.
- 1 July 2009
- Published by Elsevier in SSRN Electronic Journal
Input Constraints and the Efficiency of Entry: Lessons from Cardiac Surgery
Prior studies suggest that, with elastically supplied inputs, free entry may lead to an inefficiently high number of firms in equilibrium. Under input scarcity, however, the welfare loss from free entry is reduced. Further, free entry may increase use of high-quality inputs, as oligopolistic firms underuse these inputs when entry is constrained. We assess these predictions by examining how the 1996 repeal of certificate-of-need (CON) legislation in Pennsylvania affected the market for cardiac surgery in the state. We show that entry led to a redistribution of surgeries to higher-quality surgeons and that this entry was approximately welfare neutral.
- 26 September 2007
- Published by Wiley in Strategic Management Journal
- Vol. 29 (2) , 173-193
Does focus improve operational performance? Lessons from the management of clinical trials
For over three decades, the benefits of focus have been touted under the guiding principle that dedicated attention to a small set of linked tasks improves operating performance. Numerous studies have suggested that the performance of a division, plant, or business unit is improved to the extent that it remains focused on a narrow range of activities. Others have found similar benefits associated with focus at the level of the entire firm. A question that has received less attention, however, is whether focus at the divisional level is complementary with, or a substitute for, focus at the firm level. We explore this question by considering the performance of investigative sites in biopharmaceutical clinical trials. First, we establish that firms focusing on a particular task—at either a divisional or firm level—experience higher output and productivity with respect to that task than unfocused firms. After controlling for selection, scale, and learning effects, we find that sites that focus on conducting clinical trials significantly outperform those that mix trial activity with the provision of traditional patient care. Second, we find evidence that focus at the divisional level and firm level are substitutes. That is, organizations characterized by divisional focus alone achieve statistically similar performance to sites that are characterized by both divisional and firm focus. Copyright © 2007 John Wiley & Sons, Ltd.
- 26 September 2007
- Published by Wiley in Strategic Management Journal
- Vol. 29 (2) , 173-193
Does focus improve operational performance? Lessons from the management of clinical trials
For over three decades, the benefits of focus have been touted under the guiding principle that dedicated attention to a small set of linked tasks improves operating performance. Numerous studies have suggested that the performance of a division, plant, or business unit is improved to the extent that it remains focused on a narrow range of activities. Others have found similar benefits associated with focus at the level of the entire firm. A question that has received less attention, however, is whether focus at the divisional level is complementary with, or a substitute for, focus at the firm level. We explore this question by considering the performance of investigative sites in biopharmaceutical clinical trials. First, we establish that firms focusing on a particular task—at either a divisional or firm level—experience higher output and productivity with respect to that task than unfocused firms. After controlling for selection, scale, and learning effects, we find that sites that focus on conducting clinical trials significantly outperform those that mix trial activity with the provision of traditional patient care. Second, we find evidence that focus at the divisional level and firm level are substitutes. That is, organizations characterized by divisional focus alone achieve statistically similar performance to sites that are characterized by both divisional and firm focus. Copyright © 2007 John Wiley & Sons, Ltd.
- 31 January 2006
- Published by Elsevier in Journal of Health Economics
- Vol. 25 (1) , 58-80
Hospital integration and vertical consolidation: An analysis of acquisitions in New York State
- 31 January 2006
- Published by Elsevier in Journal of Health Economics
- Vol. 25 (1) , 58-80
Hospital integration and vertical consolidation: An analysis of acquisitions in New York State
- 3 March 2005
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 352 (9) , 857-859
Turf Battles in Coronary Revascularization
When percutaneous transluminal coronary angioplasty (PTCA) entered mainstream use in the early 1980s, it represented a suboptimal substitute for coronary-artery bypass grafting (CABG). Over time, however, the outcomes of PTCA improved, and the technique became a viable alternative to CABG, even in the treatment of patients with advanced coronary disease. Nevertheless, the extent of the diffusion of PTCA as compared with CABG varied widely among hospitals. Several years after the introduction of PTCA, traditional CABG surgery was faced with a new competitor — minimally invasive cardiac surgery. Although the less invasive technique had clear advantages for some types of patients, . . .
- 3 March 2005
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 352 (9) , 857-859
Turf Battles in Coronary Revascularization
When percutaneous transluminal coronary angioplasty (PTCA) entered mainstream use in the early 1980s, it represented a suboptimal substitute for coronary-artery bypass grafting (CABG). Over time, however, the outcomes of PTCA improved, and the technique became a viable alternative to CABG, even in the treatment of patients with advanced coronary disease. Nevertheless, the extent of the diffusion of PTCA as compared with CABG varied widely among hospitals. Several years after the introduction of PTCA, traditional CABG surgery was faced with a new competitor — minimally invasive cardiac surgery. Although the less invasive technique had clear advantages for some types of patients, . . .